Ex-House Leader Cantor Named PhRMA CEO

The US drug lobby group PhRMA has named former House leader Eric Cantor as its new CEO. Cantor, a former Republican House Majority Leader, will be taking over as the president of the organization.

PhRMA is the leading lobbying and trade organization for the U.S. pharmaceutical industry, and the announcement of Cantor's new role was made on a Tuesday.

The move marks a significant development in the pharmaceutical industry, with Cantor bringing his experience as a former House leader to the role.

## What it means The appointment of Cantor as PhRMA's new president is likely to have significant implications for the pharmaceutical industry. As the leading lobbying and trade organization, PhRMA plays a crucial role in shaping the industry's direction and advocating for its interests. With Cantor at the helm, the organization is likely to continue to push for policies that benefit the industry.

## Why it matters The pharmaceutical industry is a critical sector in the US economy, and PhRMA's lobbying efforts can have a significant impact on the industry's growth and development. The appointment of Cantor as CEO is likely to be closely watched by industry stakeholders, policymakers, and consumers alike. As the industry continues to evolve and face new challenges, PhRMA's leadership will play a key role in shaping its future.